Oxybutynine Biogaran (Oxybutynin Hydrochloride)

Oxybutynin hydrochloride, the active ingredient in Oxybutynine Biogaran, is an antimuscarinic agent presented as an oral tablet for oral administration. It reduces involuntary bladder contractions, thereby alleviating urinary urgency, frequency and urge incontinence in adult patients diagnosed with overactive bladder or related detrusor overactivity.

GNH USA supplies Oxybutynine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under stringent quality standards and meeting EU regulatory requirements.

Oxybutynin is an antimuscarinic medication used to manage symptoms of overactive bladder and related disorders.

- Overactive bladder: reduces urinary urgency, frequency and incontinence episodes. - Urge urinary incontinence: decreases the number of leakage events during the day. - Neurogenic detrusor overactivity: improves bladder storage function in patients with neurological conditions.

Oxybutynin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Dizziness - Headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Acute urinary retention - Tachycardia or other arrhythmias - Exacerbation of narrow‑angle glaucoma

When prescribing oxybutynin